HomeTagsGenprex

Genprex

Healthcare

Genprex Announces U.S. Patent for REQORSA Immunogene Therapy

PR Newswire - August 17, 2022

Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that the United States Patent...

Biotechnology

Genprex to Accelerate Opening of Acclaim-1 Clinical Trial Sites for REQORSA™ Systemic Gene Therapy in Non-Small Cell Lung Cancer

Business Wire - January 11, 2022

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes,...